Montco firm reports early success with experimental Ebola vaccine
Inovio Pharmaceuticals Inc. reported on Tuesday positive results from early-stage testing of its experimental Ebola vaccine.
The Plymouth Meeting, Pa., company’s phase-I clinical trial results came a day after the World Health Organization declared the Ebola outbreak that began in West Africa is no longer a public health emergency of international concern.
That doesn’t mean work on vaccines and treatments for future outbreaks will stop.
WHO said about 11,320 people — mostly living in Guinea,…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: John George Source Type: news
More News: African Health | Clinical Trials | Ebola | Ebola Vaccine | Emergency Medicine | Health | Health Management | International Medicine & Public Health | Outbreaks | Pharmaceuticals | Vaccines | WHO